Literature DB >> 33442687

Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.

Jennifer M Dan1,2, Jose Mateus1, Yu Kato1, Kathryn M Hastie1, Esther Dawen Yu1, Caterina E Faliti1, Alba Grifoni1, Sydney I Ramirez1,2, Sonya Haupt1, April Frazier1, Catherine Nakao1, Vamseedhar Rayaprolu1, Stephen A Rawlings2, Bjoern Peters1,3, Florian Krammer4, Viviana Simon4,5,6, Erica Ollmann Saphire1,2, Davey M Smith2, Daniela Weiskopf1, Alessandro Sette1,2, Shane Crotty1,2.   

Abstract

Understanding immune memory to SARS-CoV-2 is critical for improving diagnostics and vaccines, and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥ 6 months post-infection. IgG to the Spike protein was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month post symptom onset. SARS-CoV-2-specific CD4 + T cells and CD8 + T cells declined with a half-life of 3-5 months. By studying antibody, memory B cell, CD4 + T cell, and CD8 + T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.

Entities:  

Year:  2020        PMID: 33442687      PMCID: PMC7805444          DOI: 10.1101/2020.11.15.383323

Source DB:  PubMed          Journal:  bioRxiv


  15 in total

Review 1.  Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism.

Authors:  Hyoann Choi; Mrinalini C Rao; Eugene B Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

2.  Rapid repeat infection of SARS-CoV-2 by two highly distinct delta-lineage viruses.

Authors:  Andrew J Gorzalski; Christina Boyles; Victoria Sepcic; Subhash Verma; Joel Sevinsky; Kevin Libuit; Stephanie Van Hooser; Mark W Pandori
Journal:  Diagn Microbiol Infect Dis       Date:  2022-06-22       Impact factor: 2.983

3.  Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test.

Authors:  Mariangela F Silveira; Marilia A Mesenburg; Odir A Dellagostin; Natasha R de Oliveira; Mara Ac Maia; Francisco D Santos; André Vale; Ana M B Menezes; Gabriel D Victora; Cesar G Victora; Aluisio Jd Barros; Luis Paulo Vidaletti; Fernando P Hartwig; Fernando C Barros; Pedro C Hallal; Bernardo L Horta
Journal:  Braz J Infect Dis       Date:  2021-08-05       Impact factor: 3.257

Review 4.  An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19.

Authors:  Saeede Soleimanian; Soheila Alyasin; Najmeh Sepahi; Zahra Ghahramani; Zahra Kanannejad; Ramin Yaghobi; Mohammad Hossein Karimi
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

5.  Using Robinson-Foulds supertrees in divide-and-conquer phylogeny estimation.

Authors:  Xilin Yu; Thien Le; Sarah A Christensen; Erin K Molloy; Tandy Warnow
Journal:  Algorithms Mol Biol       Date:  2021-06-28       Impact factor: 1.405

6.  Determinants of IgG antibodies kinetics after severe and critical COVID-19.

Authors:  Julien De Greef; Anaïs Scohy; Francis Zech; Frank Aboubakar; Charles Pilette; Ludovic Gerard; Lucie Pothen; Halil Yildiz; Leïla Belkhir; Jean Cyr Yombi
Journal:  J Med Virol       Date:  2021-05-12       Impact factor: 20.693

7. 

Authors:  Nicholas Brousseau; Laurianne Morin; Manale Ouakki; Patrice Savard; Caroline Quach; Yves Longtin; Matthew P Cheng; Alex Carignan; Simon F Dufresne; Jean-Michel Leduc; Christian Lavallée; Nicolas Gauthier; Julie Bestman-Smith; Maria-Jesus Arrieta; Magued Ishak; Simon Lévesque; Philippe Martin; Gaston De Serres
Journal:  CMAJ       Date:  2022-03-07       Impact factor: 16.859

8.  Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.

Authors:  Daniel Y Zhu; Matthew J Gorman; Dansu Yuan; Jingyou Yu; Noe B Mercado; Katherine McMahan; Erica N Borducchi; Michelle Lifton; Jinyan Liu; Felix Nampanya; Shivani Patel; Lauren Peter; Lisa H Tostanoski; Laurent Pessaint; Alex Van Ry; Brad Finneyfrock; Jason Velasco; Elyse Teow; Renita Brown; Anthony Cook; Hanne Andersen; Mark G Lewis; Douglas A Lauffenburger; Dan H Barouch; Galit Alter
Journal:  PLoS Biol       Date:  2022-05-05       Impact factor: 9.593

9.  Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers.

Authors:  Shelley Klompus; Sigal Leviatan; Thomas Vogl; Roei D Mazor; Iris N Kalka; Liat Stoler-Barak; Nachum Nathan; Ayelet Peres; Lihee Moss; Anastasia Godneva; Sharon Kagan Ben Tikva; Eilat Shinar; Hadas Cohen Dvashi; Ronen Gabizon; Nir London; Ron Diskin; Gur Yaari; Adina Weinberger; Ziv Shulman; Eran Segal
Journal:  Sci Immunol       Date:  2021-07-29

Review 10.  Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.

Authors:  Ahmed S Abdel-Moneim; Elsayed M Abdelwhab; Ziad A Memish
Journal:  Virology       Date:  2021-02-22       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.